Earnings Feed
Start Free
Home/Insiders/Coric Vlad
CV
SEC Insider//CIK 0001704317

Coric Vlad

CIK 00017043175 companiesNEW HAVEN, CT
SEC Profile

Transactions

50

Companies

5

Filings

10

CIK

0001704317

Recent Transactions

50 trades
  • Tax Payment
    Biohaven Ltd.$BHVN

    Common Shares

    2026-01-05$9.93/sh−7,430→ 1,803,968 total
  • Exercise/Conversion
    Biohaven Ltd.$BHVN

    Restricted Share Unit Award

    2026-01-05−14,250→ 28,500 total
  • Exercise/Conversion
    Biohaven Ltd.$BHVN

    Common Shares

    2026-01-05+14,250→ 1,811,398 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Shares

    2025-11-13$7.50/sh+333,333→ 740,546 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Shares

    2025-11-13$7.50/sh+333,333→ 1,195,275 total
  • Award
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2025-05-13+7,614→ 10,798 total
  • Award
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2025-04-21+3,184→ 3,184 total
  • Disposition to Issuer
    Revance Therapeutics, Inc.

    Common Stock

    2025-02-06−15,000→ 0 total
  • Disposition from Tender
    Revance Therapeutics, Inc.

    Common Stock

    2025-02-04$3.65/sh−5,784→ 15,000 total
  • Tax Payment
    Biohaven Ltd.$BHVN

    Common Shares

    2025-01-05$38.64/sh−6,805→ 1,796,604 total
  • Exercise/Conversion
    Biohaven Ltd.$BHVN

    Common Shares

    2025-01-05+14,250→ 1,803,409 total
  • Exercise/Conversion
    Biohaven Ltd.$BHVN

    Restricted Share Unit Award

    2025-01-05−14,250→ 42,750 total
  • Award
    Biohaven Ltd.$BHVN

    Restricted Share Unit Award

    2025-01-05+57,000→ 57,000 total
  • Award
    Biohaven Ltd.$BHVN

    Stock Options (Right to buy)

    2025-01-05+343,000→ 343,000 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Shares

    2024-10-02$47.50/sh+21,052→ 861,942 total
  • Award
    Revance Therapeutics, Inc.

    Stock Option (Right to buy)

    2024-05-01+23,458→ 23,458 total
  • Award
    Revance Therapeutics, Inc.

    Common Stock

    2024-05-01+15,000→ 20,784 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Shares

    2024-04-22$41.00/sh+121,951→ 1,788,417 total
  • Award
    Biohaven Ltd.$BHVN

    Common Shares

    2024-04-05+231→ 407,213 total
  • Award
    Biohaven Ltd.$BHVN

    Common Shares

    2024-04-05+231→ 840,890 total
  • Award
    Biohaven Ltd.$BHVN

    Common Shares

    2024-04-05+232→ 1,666,466 total
  • Award
    Biohaven Ltd.$BHVN

    Common Shares

    2024-03-08+2,162→ 1,666,234 total
  • Award
    Biohaven Ltd.$BHVN

    Common Shares

    2024-03-08+2,155→ 840,659 total
  • Award
    Biohaven Ltd.$BHVN

    Common Shares

    2024-03-08+2,155→ 406,982 total
  • Award
    Biohaven Ltd.$BHVN

    Common Shares

    2024-01-08+5,384→ 404,827 total
  • Award
    Biohaven Ltd.$BHVN

    Common Shares

    2024-01-08+5,384→ 838,504 total
  • Award
    Biohaven Ltd.$BHVN

    Common Shares

    2024-01-08+5,400→ 1,662,431 total
  • Award
    Biohaven Ltd.$BHVN

    Stock Options (Right to buy)

    2024-01-02+275,000→ 275,000 total
  • Award
    Biohaven Ltd.$BHVN

    Stock Options (Right to buy)

    2023-11-02+225,000→ 225,000 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Shares

    2023-10-05$22.00/sh+113,637→ 1,657,031 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Share

    2023-10-05$22.00/sh+340,908→ 833,120 total
  • Award
    Revance Therapeutics, Inc.

    Common Stock

    2023-05-03+589→ 5,784 total
  • Award
    Revance Therapeutics, Inc.

    Stock Option (Right to buy)

    2023-05-03+986→ 986 total
  • Award
    Revance Therapeutics, Inc.

    Stock Option (Right to buy)

    2023-03-01+8,576→ 8,576 total
  • Award
    Revance Therapeutics, Inc.

    Common Stock

    2023-03-01+5,195→ 5,195 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Stock

    2022-10-31$15.97/sh+25,800→ 1,543,394 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Shares

    2022-10-28$14.82/sh+100,000→ 109,565 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Shares

    2022-10-28$14.87/sh+41,930→ 1,517,594 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Shares

    2022-10-25$10.50/sh+853,380→ 1,475,664 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Shares

    2022-10-05$11.79/sh+52,523→ 397,343 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Shares

    2022-10-05$10.82/sh+80,606→ 344,820 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Shares

    2022-10-05$9.90/sh+34,515→ 356,976 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Shares

    2022-10-05$9.89/sh+34,459→ 264,214 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Shares

    2022-10-05$8.82/sh+73,005→ 229,755 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Shares

    2022-10-05$11.83/sh+54,329→ 492,212 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Shares

    2022-10-05$8.82/sh+73,331→ 322,461 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Shares

    2022-10-05$12.35/sh+2,100→ 399,443 total
  • Purchase
    Biohaven Ltd.$BHVN

    Common Shares

    2022-10-05$10.83/sh+80,907→ 437,883 total
  • Other
    Biohaven Ltd.$BHVN

    Common Shares

    2022-10-03+0→ 569,309 total
  • Disposition to Issuer
    Biohaven Pharmaceutical Holding Co Ltd.

    Stock Options (Right to Buy)

    2022-10-03−775→ 0 total

Companies

5

Recent Filings

10

Address

C/O BIOHAVEN LTD. 215 CHURCH STREET

NEW HAVEN, CT, 06510

View on SEC.gov